|1.||Barbieri, Giovanna: 4 articles (11/2013 - 07/2006)|
|2.||Pellerito, Lorenzo: 4 articles (11/2013 - 07/2006)|
|3.||Pellerito, Claudia: 4 articles (11/2013 - 07/2006)|
|4.||Fiore, Tiziana: 4 articles (11/2013 - 07/2006)|
|5.||Costa, Maria Assunta: 4 articles (11/2013 - 07/2006)|
|6.||Guerrini, Andrea: 2 articles (12/2015 - 01/2013)|
|7.||Serpe, Loredana: 2 articles (12/2015 - 01/2013)|
|8.||Varchi, Greta: 2 articles (12/2015 - 01/2013)|
|9.||Ballestri, Marco: 2 articles (12/2015 - 01/2013)|
|10.||Foglietta, Federica: 2 articles (12/2015 - 01/2013)|
08/01/2006 - "Photodynamic efficacy of the carrier/sensitizer system is proven by in vitro studies on tumor Hela cells treated with TPPS:SC6CDNH2 at different molar ratio, showing significant cells death upon illumination with visible light."
09/01/2015 - "Taken together, our findings provide the framework for the evaluation of the TSPP anti-tumor activity in further disease-oriented clinical trials."
08/01/2007 - "The objective of this study was to evaluate the biological behaviors of a novel (188)Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin (TPPS(4)) in normal mice and tumor-bearing mice. "
01/01/2011 - "The solid-pseudopapillary tumors of the pancreas (TSPP) are a uncommon neoplasm (1- 2% of exocrine tumors). "
05/01/2005 - "The potential tumor seeking MRI contrast agent MnTPPS(4) was labelled with the positron emitting nuclide (51)Mn in no-carrier-added (n.c.a.) form. "
|3.||Huntington Disease (Huntington's Disease)
10/01/1992 - "In the second part the fast IR snapshot FLASH method was applied to study the effect of the NMR contrast agent MnTPPS on the T1 relaxation time of experimental gliomas in rat brains. "
01/01/1990 - "In the experimental F98 rat glioma model the nuclear magnetic resonance contrast agent MnTPPS was used to increase the contrast between tumour and peritumourous brain tissue. "
10/01/1994 - "The tissue concentration of Mn-TPPS was significantly higher in the glioma tissue than the other tissues, while PK11195 pretreatment could not reduce the intratumoural Mn-TPPS concentration. "
05/01/1994 - "The synthetic metalloporphyrin gadolinium (III)-tetraphenylporphine sulfonate (TPPS) was successfully used as a contrast agent for in vivo magnetic resonance (MR) imaging of rat brain glioma. "
01/01/1994 - "Although the tissue concentration of Mn-TPPS was significantly higher in the glioma than in the contralateral brain, PK11195 pretreatment did not replace the intratumoral Mn-TPPS. "
|5.||Brain Neoplasms (Brain Tumor)
01/01/1993 - "NMR-contrast enhancement of experimental brain tumors with MnTPPS: qualitative evaluation by in vivo relaxometry."
01/01/1990 - "These results demonstrate for the first time that MnTPPS is an efficient agent for contrast enhancement of brain tumors."
01/01/1993 - "In vivo relaxometry of three brain tumors in the rat: effect of Mn-TPPS, a tumor-selective contrast agent."
12/01/1994 - "Furthermore, the effect of MRI contrast agents (GdDTPA, MnTPPS, GdTPPS) on the relaxation times of these experimental brain tumors was measured. "
01/01/1994 - "MRI contrast enhancement by Mn-TPPS in experimental rat brain tumor with peripheral benzodiazepine receptors."
|1.||Peroxynitrous Acid (Peroxynitrite)
|2.||tetraphenylporphine sulfonate (TPPS)
|3.||Polymethyl Methacrylate (Sol)
|9.||Poloxamer (Poloxamer 407)
|1.||Photochemotherapy (Photodynamic Therapy)
|4.||Patient-Controlled Analgesia (Analgesia, Patient Controlled)
|5.||Heterologous Transplantation (Xenotransplantation)